Dr Ariane Lewis discusses how we can navigate uncertainty and ambiguity about brain death by understanding clinical criteria for brain death determination and how our approaches to death are culturally and socially situated.

Dr Robert Field and Dr Yashaswini Singh join the AMA Journal of Ethics Grand Rounds series to discuss what patients and clinicians should know about private equity in health care.

Prof Ana Santos Rutschman talks about the impact of intellectual property regimes on domestic and global responses to the COVID-19 pandemic.

Dr Steven Goodman talks about the ethical and scientific implications of breaking the blind of placebo-controlled COVID-19 vaccine trials.

Dr Arthur Caplan talks about ethical issues surrounding the development, production, and use of potential SARS-CoV-2 vaccine.

Dr Caleb Alexander examines the US Food and Drug Administration's controversial decision to approve aducanumab for the treatment of Alzheimer's Disease.

Dr Mollyann Brodie talks about the about the science of polling, public opinions on COVID-19, and politically-divergent views on policy options to achieve universal health care coverage.

Drs Stefano Bertozzi and Jeffrey Mackie-Mason talk about business models of scientific publishing that advance biomedical knowledge and discovery.

Matt Wuerker talks about his artistic process in creating cartoons that speak to matters of politics and policy arising from the COVID-19 pandemic.

Which distinctions between minimally conscious states and vegetative states should clinicians consider?